Patents Examined by A M Ford
  • Patent number: 7402319
    Abstract: The present invention is a natural, cell-free tissue replacement that does not require difficult or extensive preparation made by washing tissue replacement in a solution including one or more sulfobetaines and an anionic surface-active detergent and washing the tissue replacement in serial solutions of the buffered salt to remove excess detergent. The natural, cell-free tissue replacement may be a nerve graft that supports axonal regeneration, guides the axons toward the distal nerve end and/or is immunologically tolerated. Other forms of the invention are a composition and kit prepared by the method of making a native, cell-free tissue replacement. The present invention may be modified for use in diagnostic, therapeutic, and prophylactic applications.
    Type: Grant
    Filed: September 26, 2003
    Date of Patent: July 22, 2008
    Assignee: Board of Regents, The University of Texas System
    Inventors: Christine Schmidt, Terry Hudson
  • Patent number: 7384630
    Abstract: Novel methods, tissues and compositions for increasing the pancreatic mass of a mammalian recipient including harvesting immature pancreatic tissue from a mammalian donor and transplanting said tissue into the peritoneal cavity of a mammalian recipient under conditions that allow the pancreatic tissue to become vascularized and mature, thereby developing a functioning chimeric, endocrine pancreas that produces at least insulin in the recipient. The invention also includes mammalian immature pancreatic tissue adapted for transplantation into the peritoneal cavity of a mammalian recipient for increasing the pancreatic mass of the mammalian recipient as well as methods and compositions for treatment of the pancreatic tissue, recipient immunosuppression and recipient co-stimulatory blockade.
    Type: Grant
    Filed: March 24, 2003
    Date of Patent: June 10, 2008
    Assignee: Washington University
    Inventor: Marc R. Hammerman
  • Patent number: 7381404
    Abstract: The present invention relates to altering the physical and/or chemical properties of at least part of at least one tissue in the eye. In a specific embodiment, it relates to the treatment of any eye disorder, although in particular embodiments the individual has a thickened Bruch's membrane. An activating energy source is utilized to effect a controlled diffusion enhancement and/or degradation of Bruch's membrane that enables improved diffusional transport between the choroid and retina. The individual is administered an inactivated diffusion-enhancing molecule that becomes associated with the membrane, which is then precisely exposed to an activating energy source, such as light or ultrasound.
    Type: Grant
    Filed: July 1, 2003
    Date of Patent: June 3, 2008
    Assignees: The Regents of the University of California, California Institute of Technology
    Inventors: Daniel M. Schwartz, Scott Fraser, Robert H. Grubbs, Justin P. Gallivan, Changjun Yu
  • Patent number: 7371410
    Abstract: A bone graft substitute composition can include essentially of calcium sulfate, a mixing solution, and a plasticizing substance. A bone graft substitute composition can include calcium sulfate, demineralized bone matrix, cancellous bone, a plasticizing substance, and a mixing solution.
    Type: Grant
    Filed: January 30, 2002
    Date of Patent: May 13, 2008
    Assignee: Wright Medical Technology, Inc.
    Inventor: Donald W. Petersen
  • Patent number: 7371409
    Abstract: A bone graft substitute composition can include essentially of calcium sulfate, a mixing solution, and a plasticizing substance. A bone graft substitute composition can include calcium sulfate, demineralized bone matrix, cancellous bone, a plasticizing substance, and a mixing solution.
    Type: Grant
    Filed: September 6, 2001
    Date of Patent: May 13, 2008
    Assignee: Wright Medical Technology, Inc.
    Inventors: Donald W. Petersen, Barbara E. Blum
  • Patent number: 7371575
    Abstract: The present invention concerns methods for the ex vivo formation of mammalian bone and subsequent uses of the bone. A critical and distinguishing feature of the present invention are defined tissue culture conditions and factors resulting in the formation of bone cell spheroids. The invention also provides for methods of implanting into subjects the ex vivo formed bone. Also described are methods for genetically altering the bone cell spheroids to affect bone formation, identification of candidate modulators of bone formation, and identification of genes involved in bone formation.
    Type: Grant
    Filed: June 8, 2004
    Date of Patent: May 13, 2008
    Assignee: The Regents of The University of Michigan
    Inventors: Sujata Kale, Michael W. Long
  • Patent number: 7371408
    Abstract: A bone graft substitute composition comprising calcium sulfate; a mixing solution selected from the group consisting of sterile water, sodium chloride, phosphate buffered saline, potassium chloride, and sodium sulfate; and a plasticizing substance selected from the group consisting of carboxymethylcellulose, polyvinyl alcohol, methycellulose, and hydroxypropyl methylcellulose.
    Type: Grant
    Filed: June 7, 1999
    Date of Patent: May 13, 2008
    Assignee: Wright Medical Technology, Inc.
    Inventors: Donald W. Petersen, Warren O. Haggard, Donald A. Randolph, Cary P. Hagan
  • Patent number: 7354764
    Abstract: In a method for culturing cells (2), according to which cells (2) are introduced into a cell culture chamber in order to form a cellular layer, the chamber being configured inside a carrier structure (1). The shape and size of the carrier structure (1) correspond to the shape that is to be formed by the cells (2), such as an implant or a prosthesis. Nutrients and oxygen are fed to the carrier structure (1). The exterior of the carrier structure (1) is provided with a boundary membrane (4) that is impermeable to cells.
    Type: Grant
    Filed: July 28, 2003
    Date of Patent: April 8, 2008
    Assignee: Bionethos Holding
    Inventor: Augustinus Bader
  • Patent number: 7348135
    Abstract: An assay for assessing the permeability of mitochondrial membranes is provided. The assay is based on enzymatic reactions that produce a detectable signal in the presence of intra-mitochondrial compounds. In some embodiments, the intra-mitochondrial compounds may be reduced and/or oxidized nicotinamide adenine dinucleotides (i.e., NADH and NAD+, respectively). The assay may optionally be provided in the form of a kit, and may further be useful in the discovery and interrogation of compounds that may serve to inhibit pathologic increase in mitochondrial membrane permeability, which is associated with numerous and varied mammalian disease.
    Type: Grant
    Filed: August 26, 2004
    Date of Patent: March 25, 2008
    Assignee: University of Maryland
    Inventors: Tibor Kristian, Gary Fiskum
  • Patent number: 7343402
    Abstract: In an MFP apparatus according to the present invention, a communication I/F 34 communicates with at least another MFP apparatus or a server via a network. A storage section 37 stores the data received via the communication I/F 34. Then, a CPU 21 performs control in such a manner that it organizes information about customized data in the form of a data file, applies to the server via the communication section for the registration of the data file, and transmits the customize data to another MFP apparatus via the communication section on the basis of the request of the server, or that it requests another MFP apparatus to acquire customized data and stores the customized data transmitted on the basis of the request into the storage section.
    Type: Grant
    Filed: March 10, 2003
    Date of Patent: March 11, 2008
    Assignees: Kabushiki Kaisha Toshiba, Toshiba Tec Kabushiki Kaisha
    Inventor: Takahiro Hagiwara
  • Patent number: 7340519
    Abstract: A method of configuring a network element such that a Virtual Private Network (VPN) site can connect to the network element is disclosed. An interface on a Provider Edge (PE) router is configured in restricted mode. A request is received from the interface to authenticate a user associated with a VPN requesting to connect to the interface. A determination is made as to whether the user is authorized to submit requests to the interface. If the user is authorized, an activation request is received from the interface to allow the VPN can connect to the interface. A determination is made as to whether the user is authorized to connect to the interface via the VPN. If the user is authorized, VPN site parameters are configured at the PE router and the PE router is configured in unrestricted mode.
    Type: Grant
    Filed: March 5, 2003
    Date of Patent: March 4, 2008
    Assignee: AT&T Corp.
    Inventors: Joseph Golan, Joseph Thomas O'Neil
  • Patent number: 7326570
    Abstract: Provided are methods and compositions for constructing stable mammalian embryonic epithelial tissues and organs as well as constructing kidney tissue, and treating renal failure. Disclosed are methods of using an active epithelial growth factor having the capability of effectuating induction of growth and morphognesis is cells.
    Type: Grant
    Filed: June 27, 2003
    Date of Patent: February 5, 2008
    Assignee: The Regents of the University of California
    Inventors: Sanjay Kumar Nigam, Hiroyuki Sakurai, Kevin T. Bush
  • Patent number: 7323333
    Abstract: The subject invention pertains to materials and methods for inhibiting process formation and extension by cells in culture. The subject invention further includes cultures of process-forming cells wherein formation and extension of processes have been inhibited. In another aspect, the subject invention concerns methods of transplantation using process-forming cells that have been cultured by the process-inhibiting methods of the invention.
    Type: Grant
    Filed: March 31, 2004
    Date of Patent: January 29, 2008
    Assignees: University of South Florida, University of Chile
    Inventors: Pablo Caviedes, Raul Caviedes, Thomas B. Freeman, Juan A. Asenjo, Barbara A. Andrews, Dario SepĂșlveda, Christian Arriagada, Julio Salazar Rivera
  • Patent number: 7320020
    Abstract: Email senders may transmit emails over the internet to a mail server that handles emails for a plurality of users (clients). The mail server may use a spam filter to remove the spam and then transmit the filtered emails to the addressed clients. The spam filter may use a white list, black list, probability filter and keyword filter. The probability filter may use a user mail corpus and a user spam corpus for creating a user probability table that lists tokens and the probability that an email is a spam if the email contains the token. The probability filter may also use a general mail corpus and a general spam corpus for creating a general probability table that. Tokens of incoming emails may be searched for in the user probability table, and if not found, the general probability table to calculate the probability that the email is a spam.
    Type: Grant
    Filed: April 17, 2003
    Date of Patent: January 15, 2008
    Assignee: The Go Daddy Group, Inc.
    Inventors: Michael Christopher Chadwick, Adam Thomas Sink, Blake Schwendiman
  • Patent number: 7300793
    Abstract: A method for the prevention of the adhesion of particles, in particular cells and cellular components in solution to surfaces, characterized in that to the solution is added at least one polyalcohol.
    Type: Grant
    Filed: July 17, 2002
    Date of Patent: November 27, 2007
    Assignee: Evotec Technologies GmbH
    Inventor: Gabriele Gradl
  • Patent number: 7294352
    Abstract: Active enamel substances may be used for the preparation of a pharmaceutical or cosmetic composition for healing of a wound, improving healing of a wound, soft tissue regeneration or repair, or for preventing or treating infection or inflammation.
    Type: Grant
    Filed: October 30, 2003
    Date of Patent: November 13, 2007
    Assignee: Biora BioEx AB
    Inventors: Stina Gestrelius, Lars Hammarström, Petter Lyngstadaas, Christer Andersson, Ivan Slaby, Tomas Hammargren
  • Patent number: 7294334
    Abstract: Methods, devices, kits and compositions to treat a myocardial infarction. In one embodiment, the method includes the prevention of remodeling of the infarct zone of the ventricle using a combination of therapies. The method may include the introduction of structurally reinforcing agents. In other embodiments, agents may be introduced into a ventricle to increase compliance of the ventricle. The prevention of remodeling may include the prevention of thinning of the ventricular infarct zone. Another embodiment includes the reversing or prevention of ventricular remodeling with electro-stimulatory therapy. The unloading of the stressed myocardium over time effects reversal of undesirable ventricular remodeling. These therapies may be combined with structurally reinforcing therapies. In other embodiments, the structurally reinforcing component may be accompanied by other therapeutic agents. These agents may include but are not limited to pro-fibroblastic and angiogenic agents.
    Type: Grant
    Filed: March 16, 2004
    Date of Patent: November 13, 2007
    Assignee: Advanced Cardiovascular Systems, Inc.
    Inventors: Eugene T. Michal, Jeffrey Ross
  • Patent number: 7291500
    Abstract: In order to grow an object to be cultivated or grown, a growth object is encapsulated in a vessel, and the growth object is grown without substantial influence of gravity.
    Type: Grant
    Filed: May 18, 2005
    Date of Patent: November 6, 2007
    Assignees: Mitsubishi Heavy Industries, Ltd.
    Inventors: Masaru Uemura, Jun-ichiro Gyotoku, Makoto Asashima
  • Patent number: 7291179
    Abstract: Bone graft substitute compositions and methods of making the compositions are disclosed. In some embodiments, a method of making a composition includes contacting a mixing solution with a first mixture having calcium sulfate hemihydrate and a plasticizing material to form a second mixture; waiting a predetermined period of time after forming said second mixture; and then contacting demineralized bone with the second mixture to form the composition. A composition can be formed from a kit including a first mixture having calcium sulfate hemihydrate and a plasticizing substance, a second mixture having demineralized bone, and a mixing solution. The first and second mixtures and the mixing solution are unblended.
    Type: Grant
    Filed: May 30, 2003
    Date of Patent: November 6, 2007
    Assignee: Wright Medical Technology, Inc.
    Inventors: Leasa C. Miller, Kelly Coupe Richelsoph, Jon P. Moseley
  • Patent number: 7257644
    Abstract: Providing presence tracking of nodes of a logical network in a distributed computing system. Each node in a logical network tracks the presence of all other nodes on the network. This presence information is used by the protocol to optimize bandwidth utilization of the shared physical media, by not attempting to communicate with a device that does not appear to be or is unlikely to be present. In one embodiment, the presence tracking is applied to a power line carrier (PLC) physical media because of PLC's low-bandwidth characteristics, low baud rate characteristics and the widespread usage of plugged-in devices, the presence of which on the network is generally more transient by nature.
    Type: Grant
    Filed: September 19, 2002
    Date of Patent: August 14, 2007
    Assignee: Microsoft Corporation
    Inventors: Guillaume Simonnet, Harry S. Pyle